Over the past year, Sanofi and Alnylam have been retooling their 2014 R&D pact around Alnylam’s RNA tech; today, the pair signaled its end, and former Sanofi partner Regeneron has stepped in. First up, let’s look at the original deal: The French pharma-U.S. …
See Original Article
Holding on to good people is a challenge, especially in the accounting profession, where the demand for skilled CPAs is high. To help with that, many
See Original Article
Donald Trump is preparing a novel campaign strategy for a president who's pulling the U.S. from the international Paris accord on climate change,
See Original Article
Professional partnerships require hard work, according to ConvergenceCoaching founder and leading consultant Jennifer Wilson, who offers
See Original Article
Snap Inc. rallied in pre-market trading on Monday, building on recent momentum that has helped the stock more than double from a December low, and which has put it on track to open at its highest level since August. The stock rose 4.3 percent before the …
See Original Article